Jefferson’s Andrew Chapman tells us what it’s like to be the first geriatric oncology expert to run a cancer center

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

How’s this for cancer center trivia: Andrew Chapman is the first geriatric oncology expert to run an NCI-designated cancer center. Ever. A “lifer” who spent nearly three decades at Thomas Jefferson University, Chapman became the director of the Sidney Kimmel Cancer Center last March, 14 months before the deadline for NCI’s P30 Cancer Center Support...

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe
Paul Goldberg
Editor & Publisher
Table of Contents

YOU MAY BE INTERESTED IN

Oxaliplatin-based chemotherapy significantly improves survival only in stage 3 colorectal cancer patients aged 70 or younger, according to a study conducted by researchers at Korea University Guro Hospital and Korea University College of Medicine. For patients over 70, the drug offered no survival advantage and led to higher rates of treatment discontinuation due to toxicity. 
Paul Goldberg
Editor & Publisher

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login